» Articles » PMID: 21934706

Alagille Syndrome: Pathogenesis, Diagnosis and Management

Overview
Journal Eur J Hum Genet
Specialty Genetics
Date 2011 Sep 22
PMID 21934706
Citations 141
Authors
Affiliations
Soon will be listed here.
Abstract

Alagille syndrome (ALGS), also known as arteriohepatic dysplasia, is a multisystem disorder due to defects in components of the Notch signalling pathway, most commonly due to mutation in JAG1 (ALGS type 1), but in a small proportion of cases mutation in NOTCH2 (ALGS type 2). The main clinical and pathological features are chronic cholestasis due to paucity of intrahepatic bile ducts, peripheral pulmonary artery stenosis, minor vertebral segmentation anomalies, characteristic facies, posterior embryotoxon/anterior segment abnormalities, pigmentary retinopathy, and dysplastic kidneys. It follows autosomal dominant inheritance, but reduced penetrance and variable expression are common in this disorder, and somatic/germline mosaicism may also be relatively frequent. This review discusses the clinical features of ALGS, including long-term complications, the clinical and molecular diagnosis, and management.

Citing Articles

Association between autoimmune disease and neurodevelopmental disorder: a Mendelian randomization analysis.

Qin J, Zhang Y, Hu R, Lin M, Yu R, Hua Y Ital J Pediatr. 2025; 51(1):76.

PMID: 40082977 PMC: 11905720. DOI: 10.1186/s13052-025-01910-2.


Reviewing the Genetic and Molecular Foundations of Congenital Spinal Deformities: Implications for Classification and Diagnosis.

Samarkhanova D, Zhabagin M, Nadirov N J Clin Med. 2025; 14(4).

PMID: 40004644 PMC: 11856472. DOI: 10.3390/jcm14041113.


The burden of Alagille syndrome: uncovering the potential of emerging therapeutics - a comprehensive systematic literature review.

Bufler P, Howard R, Quadrado L, Lacey G, Terner-Rosenthal J, Goldstein A J Comp Eff Res. 2025; 14(2):e240188.

PMID: 39807752 PMC: 11773862. DOI: 10.57264/cer-2024-0188.


RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis.

Lam W, Gabernet G, Poth T, Sator-Schmitt M, Oquendo M, Kast B EMBO Rep. 2025; 26(3):880-907.

PMID: 39747668 PMC: 11811172. DOI: 10.1038/s44319-024-00356-7.


Whole-exome sequencing reveals the genetic causes and modifiers of moyamoya syndrome.

Nakamura A, Nomura S, Hara S, Thamamongood T, Maehara T, Nariai T Sci Rep. 2024; 14(1):22720.

PMID: 39367156 PMC: 11452616. DOI: 10.1038/s41598-024-72043-5.


References
1.
Oda T, Elkahloun A, Pike B, Okajima K, Krantz I, Genin A . Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet. 1997; 16(3):235-42. DOI: 10.1038/ng0797-235. View

2.
Dhorne-Pollet S, Deleuze J, Hadchouel M, Bonaiti-Pellie C . Segregation analysis of Alagille syndrome. J Med Genet. 1994; 31(6):453-7. PMC: 1049922. DOI: 10.1136/jmg.31.6.453. View

3.
Emerick K, Rand E, Goldmuntz E, Krantz I, Spinner N, Piccoli D . Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology. 1999; 29(3):822-9. DOI: 10.1002/hep.510290331. View

4.
Kamath B, Thiel B, Gai X, Conlin L, Munoz P, Glessner J . SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and copy number variation. Hum Mutat. 2008; 30(3):371-8. PMC: 2650004. DOI: 10.1002/humu.20863. View

5.
Deprettere A, Portmann B, Mowat A . Syndromic paucity of the intrahepatic bile ducts: diagnostic difficulty; severe morbidity throughout early childhood. J Pediatr Gastroenterol Nutr. 1987; 6(6):865-71. DOI: 10.1097/00005176-198711000-00008. View